APA aipamena

Ellis, N. A., Huo, D., Yildiz, O., Worrillow, L. J., Banerjee, M., Le Beau, M. M., . . . Onel, K. (2008). MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility. American Society of Hematology.

Chicago Style aipamena

Ellis, Nathan A., Dezheng Huo, Ozlem Yildiz, Lisa J. Worrillow, Mekhala Banerjee, Michelle M. Le Beau, Richard A. Larson, James M. Allan, and Kenan Onel. MDM2 SNP309 and TP53 Arg72Pro Interact to Alter Therapy-related Acute Myeloid Leukemia Susceptibility. American Society of Hematology, 2008.

MLA aipamena

Ellis, Nathan A., et al. MDM2 SNP309 and TP53 Arg72Pro Interact to Alter Therapy-related Acute Myeloid Leukemia Susceptibility. American Society of Hematology, 2008.